CELLSTORY PLUS CELLPLANT MESO-CARE PROGRAM (1 WEEK)
niacinamide, adenosine kit |
| Product Information |
| Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 71619-003 |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-003-01 | 1 in 1 BOX; Type 0: Not a Combination Product | 02/20/2020 | |
|
| Quantity of Parts |
| Part # | Package Quantity | Total Product Quantity |
| Part 1 | 1 CONTAINER | 1 mL |
| Part 2 | 1 CONTAINER | 1 mL |
| Part 3 | 1 CONTAINER | 1 mL |
| Part 4 | 1 CONTAINER | 1 g |
| Part 5 | 1 CONTAINER | 1.5 g |
| Part 6 | 1 CONTAINER | 4 g |
| Part 7 | 1 CONTAINER | 2 mL |
| Part 8 | 1 POUCH | 30 g |
|
| Part 1 of 8 |
CELLSTORY PLUS CELL CLEANSER
glycerin liquid |
|
| Product Information |
| Item Code (Source) | NDC: 71619-090 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) | GLYCERIN | 0.05 g in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
| DECYL GLUCOSIDE (UNII: Z17H97EA6Y) | |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-090-02 | 4 in 1 CARTON | | |
| 1 | NDC: 71619-090-01 | 1 mL in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/20/2020 | |
|
| Part 2 of 8 |
CELLSTORY PLUS CELL FLUID
niacinamide, adenosine liquid |
|
| Product Information |
| Item Code (Source) | NDC: 71619-100 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.02 g in 1 mL |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0004 in 1 mL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-100-02 | 4 in 1 CARTON | | |
| 1 | NDC: 71619-100-01 | 1 mL in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/21/2020 | |
|
| Part 3 of 8 |
CELLSTORY PLUS CELL AWAKE ESSENCE
niacinamide, adenosine liquid |
|
| Product Information |
| Item Code (Source) | NDC: 71619-110 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.02 g in 1 mL |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0004 in 1 mL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-110-01 | 1 mL in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/20/2020 | |
|
| Part 4 of 8 |
CELLSTORY PLUS CELL RECOVERY
niacinamide, adenosine cream |
|
| Product Information |
| Item Code (Source) | NDC: 71619-160 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0004 g in 1 g |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.02 g in 1 g |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-160-02 | 4 in 1 CARTON | | |
| 1 | NDC: 71619-160-01 | 1 g in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/20/2020 | |
|
| Part 5 of 8 |
CELLSTORY PLUS CELLPLANT MESO CARE
niacinamide, adenosine liquid |
|
| Product Information |
| Item Code (Source) | NDC: 71619-130 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.03 g in 1.5 g |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0006 in 1.5 g |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| GLYCERETH-26 (UNII: NNE56F2N14) | |
| WATER (UNII: 059QF0KO0R) | |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-130-01 | 1.5 g in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/21/2020 | |
|
| Part 6 of 8 |
CELLSTORY PLUS CELL ULTRA
niacinamide, adenosine gel |
|
| Product Information |
| Item Code (Source) | NDC: 71619-140 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0016 in 4 g |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.08 g in 4 g |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| BUTYLENE GLYCOL (UNII: 3XUS85K0RA) | |
| WATER (UNII: 059QF0KO0R) | |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-140-02 | 4 in 1 CARTON | | |
| 1 | NDC: 71619-140-01 | 4 g in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/21/2020 | |
|
| Part 7 of 8 |
CELLSTORY PLUS CELL ACTIVATOR AMPOULE
niacinamide, adenosine liquid |
|
| Product Information |
| Item Code (Source) | NDC: 71619-120 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.04 g in 2 mL |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0008 in 2 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
| BUTYLENE GLYCOL (UNII: 3XUS85K0RA) | |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-120-01 | 2 mL in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/21/2020 | |
|
| Part 8 of 8 |
CELLSTORY PLUS CELL CALMING MASK
niacinamide, adenosine patch |
|
| Product Information |
| Item Code (Source) | NDC: 71619-170 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.6 g in 30 g |
| ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.012 g in 30 g |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 71619-170-01 | 30 g in 1 POUCH; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/21/2020 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/20/2020 | |
|